Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
A novel orf virus vector-based COVID-19 booster vaccine shows cross-neutralizing activity in the absence of anti-vector neutralizing immunity.
Journal: Human vaccines & immunotherapeutics
Published: October 14, 2024
Immunogenicity and Safety Following 1 Dose of AS01E-Adjuvanted Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults: A Phase 3 Trial.
Journal: The Journal of infectious diseases
Published: August 22, 2023
Efficacy and Safety of an Ad26.RSV.preF-RSV preF Protein Vaccine in Older Adults.
Journal: The New England journal of medicine
Published: February 15, 2023
Long-term immunogenicity and safety of the hepatitis B vaccine HepB-CpG (HEPLISAV-B) compared with HepB-Eng (Engerix-B) in adults with chronic kidney disease.
Journal: Vaccine
Published: December 22, 2022
Immunogenicity and safety of concomitant and sequential administration of yellow fever YF-17D vaccine and tetravalent dengue vaccine candidate TAK-003: A phase 3 randomized, controlled study.
Journal: PLoS neglected tropical diseases
Published: June 24, 2022
Adipose-Derived Regenerative Cell Transplantation for the Treatment of Hand Dysfunction in Systemic Sclerosis: A Randomized Clinical Trial.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: November 10, 2021
SARS-CoV-2 DNA Vaccine INO-4800 Induces Durable Immune Responses Capable of Being Boosted in a Phase 1 Open-Label Trial.
Journal: The Journal of infectious diseases
Published: September 27, 2021
Author Correction: Anthropogenic modification of forests means only 40% of remaining forests have high ecosystem integrity.
Journal: Nature communications
Published: January 21, 2021
Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial.
Journal: EClinicalMedicine
Published: October 16, 2020
Anthropogenic modification of forests means only 40% of remaining forests have high ecosystem integrity.
Journal: Nature communications
Published: May 18, 2020
Safety and immunogenicity of a vaccine for extra-intestinal pathogenic Escherichia coli (ESTELLA): a phase 2 randomised controlled trial.
Journal: The Lancet. Infectious diseases
Published: July 30, 2018
Randomized, Double-Blind, Placebo-Controlled Trial of Intraarticular Trans-Capsaicin for Pain Associated With Osteoarthritis of the Knee.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: July 03, 2018
Last Updated: 09/26/2026